These results, together with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the strategy of focusing on ACKR3 as a unique solution to modulate the opioid process, which could open new therapeutic avenues for opioid-similar Diseases. If you have questions on https://felixyunew.bloggosite.com/32978002/rumored-buzz-on-conolidine